SCHEMBL22985186

SCHEMBL22985186

Cc1ccc2c(c1)c1ccccc1n2-c1cccc(C#N)c1-c1c(-c2ccc(C(F)(F)F)cc2C#N)cccc1-n1c2ccccc2c2cc(C)ccc21

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.35
HRH1 P35367 2/20 0.35
KIF11 P52732 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.33
TSHR P16473 1/20 0.33
PTGDR2 Q9Y5Y4 3/20 0.33
GRM2 Q14416 1/20 0.32
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
SCN9A Q15858 1/20 0.31
ALOX5AP P20292 1/20 0.31
FEN1 P39748 1/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31
PIK3CG P48736 1/20 0.31
PDK2 Q15119 1/20 0.31
AR P10275 1/20 0.31
CNR2 P34972 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985180 0.96 HTR6 (0.35) HTR6HRH1KIF11SMN1; SMN2TSHR
SCHEMBL22985184 0.93 AR (0.36) HTR6HRH1KIF11SMN1; SMN2TSHR
SCHEMBL20848792 0.93 HTR6 (0.34) HTR6HRH1KIF11SMN1; SMN2TSHR
SCHEMBL22985424 0.92 AR (0.37) HTR6HRH1KIF11SMN1; SMN2TSHR
SCHEMBL22985647 0.92 AR (0.41) KIF11SMN1; SMN2TSHRALOX5APFEN1
SCHEMBL22985185 0.91 KIF11 (0.36) HTR6HRH1KIF11SMN1; SMN2TSHR
SCHEMBL22985425 0.90 AR (0.34) HTR6HRH1KIF11SMN1; SMN2TSHR
SCHEMBL22984989 0.90 AR (0.34) HTR6HRH1KIF11SMN1; SMN2TSHR
SCHEMBL22985446 0.90 KIF11 (0.33) HTR6HRH1KIF11SCN9AALOX5AP
SCHEMBL22985646 0.90 KIF11 (0.33) HTR6HRH1KIF11SCN9AALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 HTR6 1860/4885HRH1 4849/4885KIF11 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.